Large-scale testing (Phase 3)Looking for participantsNCT06881992What this trial is testingErsodetug in Patients With Tumor HyperinsulinismWho this might be right forTumor Hyperinsulinism (Tumor HI) Rezolute 16
Testing effectiveness (Phase 2)Ended earlyNCT04171700What this trial is testingEvaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR GenesWho this might be right forSolid Tumor pharmaand GmbH 83
Large-scale testing (Phase 3)Active Not RecruitingNCT03914612What this trial is testingTesting the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial CancerWho this might be right forEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated CarcinomaEndometrial Endometrioid Adenocarcinoma+13 more National Cancer Institute (NCI) 813
Testing effectiveness (Phase 2)Study completedNCT02050919What this trial is testingSorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue SarcomaWho this might be right forPleomorphic RhabdomyosarcomaStage IIB Adult Soft Tissue Sarcoma AJCC v7Stage III Adult Soft Tissue Sarcoma AJCC v7+1 more OHSU Knight Cancer Institute 20
Early research (Phase 1)Study completedNCT00288431What this trial is testingSafety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)Who this might be right forCancerSarcoma Merck Sharp & Dohme LLC 37
Testing effectiveness (Phase 2)Study completedNCT00002131What this trial is testingA Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections Otsuka America Pharmaceutical 28
Large-scale testing (Phase 3)Study completedNCT00002445What this trial is testingSafety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS PatientsWho this might be right forSarcoma, KaposiHIV Infections Cytran 200
Testing effectiveness (Phase 2)Study completedNCT00918281What this trial is testingReproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) InjectionWho this might be right forSolid TumorsHigh Grade GliomasLung Cancer+4 more GE Healthcare 70
Early research (Phase 1)Study completedNCT01016730What this trial is testingBortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi SarcomaWho this might be right forAIDS-Related Kaposi SarcomaHIV InfectionRecurrent Kaposi Sarcoma National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT00002995What this trial is testingCombination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed RhabdomyosarcomaWho this might be right forSarcoma Children's Oncology Group 483
Early research (Phase 1)UnknownNCT01242072What this trial is testingIntravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With MalignanciesWho this might be right forMalignancyCancerNon Small Cell Lung Cancer+5 more Alaunos Therapeutics 12
Large-scale testing (Phase 3)WithdrawnNCT00334867What this trial is testingCombination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's SarcomaWho this might be right forSarcoma Children's Oncology Group
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00881595What this trial is testingProton Chemoradiotherapy for High-Risk Soft Tissue SarcomasWho this might be right forSoft Tissue Sarcomas University of Florida
Testing effectiveness (Phase 2)Looking for participantsNCT06367075What this trial is testingA Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue SarcomaWho this might be right forAdvanced Soft-tissue Sarcoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 53
Testing effectiveness (Phase 2)Study completedNCT02487979What this trial is testingGlembatumumab Vedotin in Treating Patients With Recurrent or Refractory OsteosarcomaWho this might be right forRecurrent Osteosarcoma National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT01288573What this trial is testingA Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens AloneWho this might be right forEwing's Sarcoma/Soft Tissue SarcomaNeuroblastomaBrain Tumors Genzyme, a Sanofi Company 46
Early research (Phase 1)Looking for participantsNCT07121946What this trial is testingThis is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin LymphomaWho this might be right forNon-Hodgkin Lymphoma Refractory/ RelapsedDLBCL - Diffuse Large B Cell LymphomaMantle Cell Lymphoma (MCL)+2 more LTZ Therapeutics, Inc. 42
Testing effectiveness (Phase 2)UnknownNCT02812654What this trial is testingIfosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma TreatmentWho this might be right forSarcoma, Soft Tissue AC Camargo Cancer Center 70
Early research (Phase 1)Looking for participantsNCT06830031What this trial is testingClinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell LymphomaWho this might be right forDiffuse Large B-cell-lymphomaDLBCL, Nos Genetic SubtypesFollicular Lymphoma Grade 3B+3 more Shanghai Exuma Biotechnology Ltd. 18